An interventional study of phacoemulsification in Presbyopia, sponsored by Dar Al Shifa Hospital. Status unknown at 1 site in Kuwait. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2021-05-27.
Sponsored by Dar Al Shifa Hospital · Not applicable, Interventional, and Treatment
phacoemulsification with insertion of EYHANCE IOL to improve near and intermediate vision
insertion of new intraocular lens enhanced for intermediate vision
336 studies on the registry are indexed under Presbyopia; 35 are open to participants now.
This study's planned enrollment of 40 is below the median of 61 across 276 interventional studies indexed under Presbyopia.
Browse Presbyopia studies →Dar Al Shifa Hospital is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 4 m, 80 cm, and 40 cm. he binocular defocus curve: The binocular defocus curve was done to evaluate the functional range of vision. The curve was obtained while the patient wearing his distance correction to provide the best distance visual acuity in both eyes. The test was performed under photopic conditions (85 candelas/m2) using ETDRS charts at a distance of 4m with the introduction of defocusing lenses from +1.00 D to -4.00 D in 0.50 D steps.
Procedure: phacoemulsification
phacoemulsification with implantation of EYEHANCE IOL
intermediate vision assessment
Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 80 cm .
Time frame: 6 months postoperatively
near vision assessment
Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 40 cm.
Time frame: 6 months postoperatively
defocus curve
The curve was obtained while the patient wearing his distance correction to provide the best distance visual acuity in both eyes. The test was performed under photopic conditions (85 candelas/m2) using ETDRS charts at a distance of 4m with the introduction of defocusing lenses from +1.00 D to -4.00 D in 0.50 D steps.
Time frame: 6 months postoperatively
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2020 (actual). Primary completion is estimated for Jul 2021, 8 months after the start.
Of 42 non-industry interventional studies with no phase under Presbyopia, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 23. This study's planned 8 months is below that.
Counting every sponsor, half of 129 studies reached it within 10 months; a quarter within 3 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dar Al Shifa Hospital